Synergistic Anti-Cancer Effects of AKT and SRC Inhibition in Human Pancreatic Cancer Cells.
10.3349/ymj.2018.59.6.727
- Author:
Kang AHN
1
;
Young Moon O
;
Young Geon JI
;
Han Jun CHO
;
Dong Hyeon LEE
Author Information
1. Department of Physiology, School of Medicine, CHA University, Seongnam, Korea. leedh@cha.ac.kr
- Publication Type:Original Article
- Keywords:
AKT;
SRC;
pancreatic cancer;
targeted therapy
- MeSH:
Blotting, Western;
Cell Line;
Cell Movement;
Cell Proliferation;
Cell Survival;
Humans*;
Neoplasm Metastasis;
Pancreatic Neoplasms*;
Phosphorylation;
Proto-Oncogene Proteins c-akt;
RNA, Messenger;
RNA, Small Interfering
- From:Yonsei Medical Journal
2018;59(6):727-735
- CountryRepublic of Korea
- Language:English
-
Abstract:
PURPOSE: To investigate the effect of combined inhibition of protein kinase B (AKT) and SRC on the growth and metastatic potential of human pancreatic cancer cells. MATERIALS AND METHODS: AKT and SRC were inhibited using 10-DEBC and PP2, respectively. The expression of their messenger RNAs were down-regulated by specific small interfering RNA (siRNA). Changes in pancreatic cancer cell growth and metastatic potential were determined using a cell viability assay and a xenotransplant model of pancreatic cancer, as well as cell migration and invasion assays. Signal proteins were analyzed by Western blot. RESULTS: The inhibitors 10-DEBC and PP2 suppressed cell proliferation in a dose-dependent fashion in pancreatic cancer cell lines MIA PaCa-2 and PANC-1. The simultaneous inhibition of AKT and SRC at low concentrations resulted in a significant suppression of cell proliferation. Knockdown of AKT2 and SRC using siRNAs also significantly decreased cell proliferation. In a pancreatic cancer model, combined treatment with 10-DEBC and PP2 also significantly suppressed the growth of pancreatic cancer. Application of 10-DEBC with PP2 significantly reduced the metastatic potential of pancreatic cancer cells by inhibiting migration and invasion. The combined inhibition suppressed the phosphorylation of mTOR and ERK in pancreatic cancer cells. CONCLUSION: Combined targeting of AKT and SRC resulted in a synergistic efficacy against human pancreatic cancer growth and metastasis.
